Actual problems of epidemiology of pneumococcal infection

Современные проблемы эпидемиологии пневмококковой инфекции
Ilya Belyayev 1
More Detail
1 Karaganda State Medical University, Laboratory of collective use, Karaganda, Kazakhstan
J CLIN MED KAZ, Volume 4, Issue 38, pp. 12-16.
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

This review dedicated to one of relevance problems of modern medicine. In this article are descripted clinical, epidemiological characteristics of pneumococcal infection. Role of pneumococcal infection in prevalence of diseases was over-viewed in childhood and adult. Importance of multicenter study of antimicrobial resistance of Streptococcus pneumonia was marked.

CITATION

Belyayev I. Actual problems of epidemiology of pneumococcal infection. Journal of Clinical Medicine of Kazakhstan. 2015;4(38):12-6.

REFERENCES

  • Hoult Dzh., Krig N. Nazvanie: Opredelitel’ bakterij Berdzhi (Determinant of bacteria Burgi), Izdatel’stvo: Mir, 1997, No. 2, pp.106-108.
  • WHO Weekly Epidemiological Record. World Health Organization, 12 January 2007, No. 1/2, pp. 82, 93–104.
  • WHO Weekly Epidemiological Record, World Health Organization, 6 April 2012, No. 14, pp.129-144.
  • Bennett J. E., Dolin R., Blaser M. J. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, Cambridge, UK: Elsevier, 2014.
  • Crook D. W., Brueggmann A. B., Sleeman K. L., Peto T. E. A. Washington, DC. Pneumococcal Carriage. The Pneumococcus. ASM Press, 2004.
  • Bluestone CD. Clinical course, complications and sequelae of acute otitis media, Pediatr. Infect. Dis. J., 2000, No.19, Suppl.5, pp.37–46.
  • Pokrovskij V. I., Briko N. I., Rjapis L. A. Streptokokki i streptokokkozy (Streptococci and Streptococcus), M.:Izdatel’skaja gruppa «Gjeotar-Media», 2006, 541 р.
  • Rjapis L. A., Briko N. I. Problema pnevmokokkovyh infekcij v Rossii (Рroblem of pneumococcal infections in Russia), Jepidemiologija i infekcionnye bolezni, 2010, No. 1, pp. 4–8.
  • Kozlov R.S. Pnevmokokki: uroki proshlogo — vzgljad v budushhee (Les-sons from the past - looking to the future), Smolensk: MAKMAH, 2010,128 p.
  • Baranov A. A., Briko N. I., Namazova-Baranova L. S. Sovremennaja kliniko-jepidemiologicheskaja harakteristika pnevmokokkovyh infekcij (Modern clinical and epidemiological characteristics of pneumococcal infections), Lechashhij vrach, 2012, No.4, pp.64-68.
  • WHO Weekly Epidemiological Record, 2008, No. 42, 2008, No.83, pp.373-384.
  • Strachunskij L. S., Belousova Ju. B., Kozlov S. N. Antibakterial’naja terapija (Prakticheskoe rukovodstvo), M.: Farmmedinform, 2000, 192 p.
  • Estimates of disease burden and cost-effectiveness. Geneva, World Health Organization, 2008.
  • Gosudarstvennaja programma razvitija zdravoohranenija Respubliki Kazahstan «Salamatty Қazaқstan» na 2011 – 2015 gody. (State Program for Development of Health of the Republic of Kazakhstan «Salamatty Ka-zakhstan» for 2011 - 2015 years.)
  • Karibaeva I. K. Mediko-social’naja i farmakojekonomicheskaja jeffektivnost’ konjugirovannoj pnevmokokkovoj vakciny v profilaktike pnevmokokkovoj infekcii u detej do 5 let (Medical and social and phar-macoeconomic effectiveness of pneumococcal conjugate vaccine in the pre-vention of pneumococcal disease in children under 5 years), Dis. PhD.- Almaty, 2015, 121 p.
  • Stratchounski LS, Kozlov RS, Appelbaum PC. Antimicrobial re-sistance of nasopharyngeal pneumococci from children fromday-care centres and orphanages in Russia: results of a unique prospective multicentre study, ClinMicrobiol Infect, 2006, V.12, No.9, pp. 853-66.
  • Bogaert D, De Groot R, Hermans PW. Streptococcus pneumonia colonization: the key to pneumococcal disease, Lancet Infect Dis, 2004, V. 4,No. 3, pp.144-54.
  • Crook D.W., Brueggmann A.B., Sleeman K.L., Peto T. E., Washington D.C. Pneumococcal Carriage. The Pneumococcus.: ASM Press, 2004.
  • Huang S.S., Hinrichsen V.L., Stevenson A.E., et al. Continued im-pact of pneumococcal conjugate vaccine on carriage in young children, Pediatrics, 2009, No.124, pp.1–11.
  • Kumar KL, Ashok V, Ganaie F, Ramesh AC. Nasopharyngeal carriage, antibiogram&serotype distribution of Streptococcus pneumonia among healthy under fivechildren, Indian J Med Res, 2014, V.140, No.2, pp.216-20.
  • Oishi K, Tamura K, Akeda Y. Global control of pneumococcal infections by pneumococcal vaccines,Trop Med Health, 2014, V.42, No. 2 Suppl, pp.83-6. 
  • Whitney CG, Farley MM, Hadler J, et al. Active Bacterial Core Sur-veillance of the Emerging Infections Program Network Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine, N Engl J Med, 2003, V.348, pp.1737–1746.
  • Shak JR, Vidal JE, Klugman KP. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx, Trends in microbiology, 2013, V.21, No.3, pp.129-135.
  • Ahl J, Melander E, Odenholt I, et al. Prevalence of penicillin-nonsusceptible Streptococcus pneumoniae in children in daycare centres subjected to an intervention to prevent dispersion, Infect Dis(Lond), 2015, V.47, No.5, pp.338-44.
  • Ahl J, Melander E, Odenholt I, et al. Prevalence of penicillin-nonsusceptible Streptococcus pneumoniae in children in daycare centres sub-jected to an intervention to prevent dispersion, Infect Dis(Lond), 2015, V.47, No.5.- P:338-44.
  • Turner P, Turner C, Jankhot A et al. A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border, PLoS One, 2012,V.7, No.5, p:e38271.
  • Krone CL, Wyllie AL, van Beek J. et al. Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness, PLoS One, 2015, V.10, No.3, p:e0119875.
  • Shak JR, Cremers AJ, Gritzfeld JF, et al. Impact of experimental hu-man pneumococcal carriage on nasopharyngeal bacterial densities in healthy adults, PLoS One, 2014,V.9, No.6, P:e98829.
  • Sanfilippo AM, Furuya Y, Roberts S, Salmon SL, Metzger DW. Allergic Lung Inflammation Reduces Tissue Invasion and Enhances Survival from Pulmonary Pneumococcal Infection in Mice, Which Correlates with Increased Expression of Transforming Growth Factor β1 and SiglecF (low) Alveolar Macrophages,Infect Immun., 2015.
  • Kozlov R. S. Pnevmokokki: uroki proshlogo - vzgljad v budushhee (Lessons from the past - looking to the future), Smolensk: MAKMAH, 2010, 128 p.
  • Johnson HL et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project, PLoS Medicine, 2010, 7, p. e1000348.
  • Irwin AD, Drew RJ, Marshall P, et al. Etiology of childhood bacteremia and timely antibiotics administration in the emergency department, Pediatrics, 2015, V.135, No.4, pp.635-42.
  • Jennifer Hamborsky, Andrew Kroger, Charles. Epidemiology and Prevention of Vaccine-Preventable Diseases The Pink Book. Wolfe Course Textbook - 13th Edition, 2015.
  • Watson DA, Musher DM. A brief history of the pneumococcus in biomedical research, Semin Respir Infect. 1999. No.14, pp.198–208.
  • Magee AD, Yother J. Requirement for capsule in colonization by Streptococcus pneumonia, Infect Immun, 2001, No.69, pp. 3755–61.
  • Bruyn GA, van Furth R. Pneumococcal polysaccharvaccines: indications, efficacy and recommendation, Eur J ClinMicrobiol Infect Dis, 1991, No.10, pp. 897–910.
  • Tuomanen EI. The biology of pneumococcal infection, Pediatr Res, 1997, V. 42, pp. 253–58.
  • Cundell DR, Gerard NP, Gerard C et al. Streptococcus pneumoniae anchor to activated human cells by the receptor for plateletactivating factor, Nature, 1995, No.377, pp. 435–38.
  • McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor, J Infect Dis, 2002, No.186, pp. 341–50.
  • Gilley RP, Orihuela CJ. Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization, Frontiers in Cellular and Infection Microbiology, 2014, No.4, pp.163.
  • Jefferson T., Ferroni E., Curtale F., et al. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old, Lancet Infect. Dis, 2006, No.6, pp. 405–410.
  • Hausdorff W.P., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes, Lancet Infect. Dis, 2005, No.5, pp. 83–93.
  • Katosova LK, Tatochenko VK, Arova AA, et al. Streptococcus pneumoniae serotypes in children with acutepneumonia and pleurisy, Zh Mikrobiol Epidemiol Immunobiol,1990, No.5, pp.23-8.
  • Hackel M., Lascols C., Bouchillon S et al. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations, Vaccine, 2013, No.31, pp: 4881–4887.
  • Doern G.V.Antimicrobial resistance with Streptococcus pneumoniae in the United States, Sem. Resp. Crit. Med, 2000, Vol. 21, No.4, pp.273-284.
  • Kaplan S.L., Mason E.O. Management of infections to antibiotic-resistant Streptococcus pneumonia, Clin. Microbiol. Rev, 1998, Vol. 11, pp.628-644.
  • Kyaw MH et al. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumonia, New England Journal of Medicine, 2006, No.354, pp.1455–1463
  • Richter S.S., Heilmann K.P., Dohrn C.L. et al. Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999-2011, Emerg. Infect. Dis, 2013, No.19, pp.1074–1083.